Literature DB >> 11711204

Alzheimer's disease and the cystatin C gene polymorphism: an association study.

K Beyer1, J I Lao, M Gómez, N Riutort, P Latorre, J L Mate, A Ariza.   

Abstract

Cystatin C is an amyloidogenic protein that colocalizes with beta-amyloid (Abeta) within arteriolar walls in Alzheimer disease (AD) brains. Recently, a coding polymorphism in the cystatin C gene (CST3) has been claimed to confer risk for the development of late-onset AD. In the present work we have tested the frequencies of CST3-A and CST3-G alleles and used chi-square and logistic regression analyses to assess the association among the CST3 polymorphism, apolipoprotein E4 (APOE4), and AD in a series of 159 AD patients and 155 controls. The CST3-A allele was seen to be an accumulation risk factor for early-onset AD. Furthermore, a synergistic association among the CST3-A allele, APOE4 and AD was found in AD patients whose ages were between 60 and 74 years.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11711204     DOI: 10.1016/s0304-3940(01)02307-2

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  16 in total

1.  A second locus for very-late-onset Alzheimer disease: a genome scan reveals linkage to 20p and epistasis between 20p and the amyloid precursor protein region.

Authors:  Jane M Olson; Katrina A B Goddard; Doreen M Dudek
Journal:  Am J Hum Genet       Date:  2002-05-15       Impact factor: 11.025

2.  Cystatin C protects neuronal cells from amyloid-beta-induced toxicity.

Authors:  Belen Tizon; Elena M Ribe; Weiqian Mi; Carol M Troy; Efrat Levy
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

3.  Cystatin C-cathepsin B axis regulates amyloid beta levels and associated neuronal deficits in an animal model of Alzheimer's disease.

Authors:  Binggui Sun; Yungui Zhou; Brian Halabisky; Iris Lo; Seo-Hyun Cho; Sarah Mueller-Steiner; Nino Devidze; Xin Wang; Anders Grubb; Li Gan
Journal:  Neuron       Date:  2008-10-23       Impact factor: 17.173

4.  Visual exploration of genetic association with voxel-based imaging phenotypes in an MCI/AD study.

Authors:  Sungeun Kim; Li Shen; Andrew J Saykin; John D West
Journal:  Conf Proc IEEE Eng Med Biol Soc       Date:  2009

5.  Serum cystatin C and the risk of Alzheimer disease in elderly men.

Authors:  J Sundelöf; J Arnlöv; E Ingelsson; J Sundström; S Basu; B Zethelius; A Larsson; M C Irizarry; V Giedraitis; E Rönnemaa; M Degerman-Gunnarsson; B T Hyman; H Basun; L Kilander; L Lannfelt
Journal:  Neurology       Date:  2008-09-30       Impact factor: 9.910

Review 6.  Cystatin C in aging and in Alzheimer's disease.

Authors:  Paul M Mathews; Efrat Levy
Journal:  Ageing Res Rev       Date:  2016-06-19       Impact factor: 10.895

7.  Overexpression of human cystatin C in transgenic mice does not affect levels of endogenous brain amyloid Beta Peptide.

Authors:  Monika Pawlik; Magdalena Sastre; Miguel Calero; Paul M Mathews; Stephen D Schmidt; Ralph A Nixon; Efrat Levy
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

8.  Complexes of amyloid-beta and cystatin C in the human central nervous system.

Authors:  Weiqian Mi; Sonia S Jung; Haung Yu; Stephen D Schmidt; Ralph A Nixon; Paul M Mathews; Fabrizio Tagliavini; Efrat Levy
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

9.  The assessment of beta amyloid, tau protein and cystatin C in the cerebrospinal fluid: laboratory markers of neurodegenerative diseases.

Authors:  Jan Mares; P Kanovsky; R Herzig; D Stejskal; J Vavrouskova; P Hlustik; H Vranova; S Burval; J Zapletalova; V Pidrman; R Obereigneru; A Suchy; J Vesely; J Podivinsky; K Urbanek
Journal:  Neurol Sci       Date:  2009-01-20       Impact factor: 3.307

10.  Evidence of linkage and association on chromosome 20 for late-onset Alzheimer disease.

Authors:  Katrina A B Goddard; Jane M Olson; Haydeh Payami; Monique van der Voet; Helena Kuivaniemi; Gerard Tromp
Journal:  Neurogenetics       Date:  2004-03-19       Impact factor: 2.660

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.